Small Caps Today

Biotech

19 Articles
The Biotech Stock Soaring 63% on Unprecedented Cancer Trial Results – Meet Janux Therapeutics
Dec 04, 2024

The Biotech Stock Soaring 63% on Unprecedented Cancer Trial Results – Meet Janux Therapeutics

5' read
Why Maravai LifeSciences Could Be a Perfect Acquisition Target for Repligen
s
scdadmin
·Aug 22, 2024

Why Maravai LifeSciences Could Be a Perfect Acquisition Target for Repligen

6' read
SmallCaps Daily Sits Down with Milton Werner, President and CEO of Inhibikase Therapeutics
s
scdadmin
·Feb 05, 2024

SmallCaps Daily Sits Down with Milton Werner, President and CEO of Inhibikase Therapeutics

15' read
Travere’s Recent Breakthrough Drug Sends Its Stock Soaring: What Investors Need To Know Now!
s
scdadmin
·Dec 11, 2023

Travere’s Recent Breakthrough Drug Sends Its Stock Soaring: What Investors Need To Know Now!

6' read
Pond Technologies: Value Through Vertical Integration Creates Catalysts For Investors
s
scdadmin
·Nov 11, 2021

Pond Technologies: Value Through Vertical Integration Creates Catalysts For Investors

17' read
Quipt Home Medical Corp: The Deeply Undervalued Home Medical Company Helping Create a Safer Post Pandemic World
s
scdadmin
·Aug 24, 2021

Quipt Home Medical Corp: The Deeply Undervalued Home Medical Company Helping Create a Safer Post Pandemic World

7' read
Massive Breakthrough for Young Biotech Company Longeveron, Shown in Promising Phase 2b Trial Results
s
scdadmin
·Aug 13, 2021

Massive Breakthrough for Young Biotech Company Longeveron, Shown in Promising Phase 2b Trial Results

6' read
Longeveron (LGVN): The Highest Growth Potential Company Presenting at the AAIC
s
scdadmin
·Aug 09, 2021

Longeveron (LGVN): The Highest Growth Potential Company Presenting at the AAIC

6' read
Safety and Tolerability of Anti-Coronavirus Drug Candidates Observed in an Animal Model Further Advances NanoViricides’ SARS-CoV-2 Therapeutics Program
s
scdadmin
·Jul 08, 2020

Safety and Tolerability of Anti-Coronavirus Drug Candidates Observed in an Animal Model Further Advances NanoViricides’ SARS-CoV-2 Therapeutics Program

9' read
Pressure Bio: The $3.5 Million Order For Hand Sanitizers Could Really Increase The Momentum Of This Stock
s
scdadmin
·Jun 12, 2020

Pressure Bio: The $3.5 Million Order For Hand Sanitizers Could Really Increase The Momentum Of This Stock

8' read
U.S. Senator Richard Blumenthal Visited NanoViricides Inc. for Update on Coronavirus Drug Development Efforts
s
scdadmin
·Apr 06, 2020

U.S. Senator Richard Blumenthal Visited NanoViricides Inc. for Update on Coronavirus Drug Development Efforts

5' read
Nemaura Medical to Launch their non-invasive continuous glucose monitor in the US market under the Wellness Category
s
scdadmin
·Mar 20, 2020

Nemaura Medical to Launch their non-invasive continuous glucose monitor in the US market under the Wellness Category

7' read
Nemaura To Prepare for Launch of sugarBEAT CGM In the U.S. Following FDA Feedback
s
scdadmin
·Mar 18, 2020

Nemaura To Prepare for Launch of sugarBEAT CGM In the U.S. Following FDA Feedback

4' read
NanoViricides to Produce Broad Spectrum Antiviral Clinical Trial Candidates for COVID-19
s
scdadmin
·Mar 04, 2020

NanoViricides to Produce Broad Spectrum Antiviral Clinical Trial Candidates for COVID-19

8' read
Avivagen’s OxC-beta™ Livestock product May Prevent Future Outbreaks Like The Wuhan Coronavirus
s
scdadmin
·Feb 20, 2020

Avivagen’s OxC-beta™ Livestock product May Prevent Future Outbreaks Like The Wuhan Coronavirus

8' read
Biotech Stocks To The Rescue: The Race to Stop The Wuhan Virus
s
scdadmin
·Jan 23, 2020

Biotech Stocks To The Rescue: The Race to Stop The Wuhan Virus

7' read

Join our newsletter 🎉

Read and share new perspectives on just about any topic. Everyone’s welcome.
  • 01Create a free account.
  • 02Write your stories.
subsc